title: Involvement of the serine protease inhibitor, SERPINE2, and the urokinase plasminogen activator in cumulus expansion and oocyte maturation.
abstract: The serpin peptidase inhibitor, clade E, member 2 (SERPINE2) inhibits urokinase-type plasminogen activator (PLAU) and tissue-type plasminogen activator. Higher SERPINE2 expression levels were detected in cumulus cells of human immature oocytes than in those of mature oocytes. The objective of this study was to evaluate whether high SERPINE2 levels in cumulus cells are associated with oocyte immaturity. Using the mouse cumulus-oocyte complex as an experimental model, the effects of elimination and overexpression of SERPINE2 in cumulus cells on cumulus expansion and oocyte maturation were assayed by in vitro maturation. Serpine2 and PLAU transcripts were the most highly expressed serpins and plasminogen activators, respectively. Their expression was coordinately regulated in cumulus cells during gonadotropin-induced oocyte maturation. Silencing of Serpine2 expression using small interfering RNAs or blockage of SERPINE2 protein using a specific antibody had no effect on oocyte maturation. However, overexpression of Serpine2 or exogenous supplementation with high levels of SERPINE2 impaired cumulus expansion and oocyte maturation, probably by decreasing hyaluronan synthase 2 (Has2) and versican (Vcan) mRNA expression. Amiloride, a specific PLAU inhibitor, also suppressed these processes. PLAU supplementation of the oocyte in vitro maturation medium caused earlier and more extensive expansion of cumulus cells and oocyte maturation that may be mediated by increased Has2 mRNA expression. However, these effects were neutralized by coincubation with SERPINE2 or amiloride and PLAU. In conclusion, SERPINE2 and PLAU are involved in cumulus expansion and oocyte maturation. High SERPINE2 levels impair these processes, probably by decreasing cumulus matrix gene expression as well as reducing cumulus hyaluronan contents and inhibiting PLAU activity. These findings may explain why cumulus cells surrounding immature human oocytes express high SERPINE2 levels.
authors.affiliation: Department of Medical Research, Mackay Memorial Hospital, Tamshui, New Taipei City, Taiwan ; Institute of Biotechnology, College of Bio-Resources and Agriculture, National Taiwan University, Taipei, Taiwan.
authors.forename: Chung-Hao
authors.initials: CH
authors.lastname: Lu
authors.forename: Robert Kuo-Kuang
authors.initials: RK
authors.lastname: Lee
authors.forename: Yuh-Ming
authors.initials: YM
authors.lastname: Hwu
authors.forename: Ming-Huei
authors.initials: MH
authors.lastname: Lin
authors.forename: Ling-Yu
authors.initials: LY
authors.lastname: Yeh
authors.forename: Ying-Jie
authors.initials: YJ
authors.lastname: Chen
authors.forename: Shau-Ping
authors.initials: SP
authors.lastname: Lin
authors.forename: Sheng-Hsiang
authors.initials: SH
authors.lastname: Li
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D049109:Cell Proliferation; D054885:Cumulus Cells / Q000166:cytology* / Q000378:metabolism*; D005109:Extracellular Matrix / Q000235:genetics; D005260:Female; D005786:Gene Expression Regulation; D020868:Gene Silencing; D006736:Horses; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism; D051379:Mice; D009865:Oocytes / Q000166:cytology* / Q000378:metabolism*; D058258:Serpin E2 / Q000378:metabolism*; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
chemical_list: D058258:Serpin E2; D006820:Hyaluronic Acid; D014568:Urokinase-Type Plasminogen Activator
references.citation: Dev Biol. 2004 Dec 1;276(1):64-73
references.pmid: 15531364
references.citation: Endocrinology. 1996 Dec;137(12):5671-7
references.pmid: 8940398
references.citation: Endocrinology. 2001 Jul;142(7):3033-40
references.pmid: 11416025
references.citation: Mol Endocrinol. 2002 Jun;16(6):1154-67
references.pmid: 12040004
references.citation: PLoS One. 2012;7(10):e47106
references.pmid: 23082142
references.citation: Biol Reprod. 2010 Oct;83(4):549-57
references.pmid: 20592310
references.citation: Hum Reprod. 2007 Nov;22(11):2842-50
references.pmid: 17872911
references.citation: Eur J Biochem. 1993 May 15;214(1):147-56
references.pmid: 8508786
references.citation: Eur J Biochem. 1997 Mar 1;244(2):487-93
references.pmid: 9119016
references.citation: Dev Biol. 2006 Jul 15;295(2):615-22
references.pmid: 16712832
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Development. 2004 Apr;131(7):1577-86
references.pmid: 14998931
references.citation: Development. 2003 May;130(10):2253-61
references.pmid: 12668637
references.citation: J Biol Chem. 1997 May 30;272(22):13997-4000
references.pmid: 9206724
references.citation: Am J Obstet Gynecol. 1994 Feb;170(2):671-6
references.pmid: 8116730
references.citation: J Biol Chem. 1985 Jun 10;260(11):7029-34
references.pmid: 3997857
references.citation: Prostate. 2004 Apr 1;59(1):1-12
references.pmid: 14991861
references.citation: Biol Reprod. 1987 May;36(4):1055-62
references.pmid: 3109510
references.citation: Matrix Biol. 2006 Aug;25(6):342-54
references.pmid: 16806868
references.citation: Biol Reprod. 2007 May;76(5):848-57
references.pmid: 17192514
references.citation: Hum Reprod Update. 1998 Mar-Apr;4(2):103-20
references.pmid: 9683349
references.citation: J Clin Invest. 1991 Oct;88(4):1067-72
references.pmid: 1833420
references.citation: Mol Cell Endocrinol. 2005 Apr 29;234(1-2):75-9
references.pmid: 15836955
references.citation: Reprod Biol Endocrinol. 2010 Oct 27;8:127
references.pmid: 20977773
references.citation: Biol Reprod. 2011 Mar;84(3):514-25
references.pmid: 21084713
references.citation: Science. 2002 Jun 21;296(5576):2178-80
references.pmid: 12077402
references.citation: J Biol Chem. 2005 Jul 8;280(27):25674-86
references.pmid: 15840581
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12446-50
references.pmid: 8618918
references.citation: Biol Reprod. 2005 Jan;72(1):195-9
references.pmid: 15385414
references.citation: Int Rev Cytol. 2004;235:251-91
references.pmid: 15219785
references.citation: Reproduction. 2001 Jan;121(1):51-75
references.pmid: 11226029
references.citation: Biol Reprod. 2004 Sep;71(3):887-93
references.pmid: 15128599
references.citation: Am J Obstet Gynecol. 1987 Aug;157(2):468-75
references.pmid: 2441605
references.citation: Cancer Biochem Biophys. 1999 Jul;17(1-2):109-23
references.pmid: 10738907
references.citation: J Biol Chem. 2007 Oct 12;282(41):30161-70
references.pmid: 17675295
references.citation: Reprod Biol Endocrinol. 2011 Mar 23;9:38
references.pmid: 21426587
references.citation: Reprod Biol Endocrinol. 2011 Aug 02;9:106
references.pmid: 21806836
references.citation: Reproduction. 2001 Dec;122(6):829-38
references.pmid: 11732978
references.citation: Endocrinology. 2004 Apr;145(4):1767-75
references.pmid: 14701676
references.citation: J Biol Chem. 2001 Mar 16;276(11):7693-6
references.pmid: 11145954
references.citation: Endocrinology. 1989 Jan;124(1):415-21
references.pmid: 2521207
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3029-33
references.pmid: 11248026
references.citation: J Clin Invest. 1991 Mar;87(3):962-70
references.pmid: 1900311
references.citation: EMBO J. 1993 May;12(5):1871-8
references.pmid: 8491179
references.citation: Mol Reprod Dev. 2003 Feb;64(2):152-65
references.pmid: 12506347